Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 15/20 | 0.57 |
| ▸ | TP53 | P04637 | 4/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25916307 | 0.93 | MAPT (0.55) | MAPTTP53RXFP1MEN1KMT2A | |
| SCHEMBL30211749 | 0.93 | MAPT (0.55) | MAPTTP53RXFP1MEN1KMT2A | |
| SCHEMBL25916842 | 0.89 | MAPT (0.66) | MAPTTP53RXFP1MEN1KMT2A | |
| SCHEMBL25916297 | 0.88 | HPGD (0.65) | MAPTTP53RXFP1HPGDALDH1A1 | |
| SCHEMBL30362775 | 0.88 | HPGD (0.65) | MAPTTP53RXFP1HPGDALDH1A1 | |
| SCHEMBL30362639 | 0.88 | MAPT (0.55) | MAPTTP53RXFP1MEN1KMT2A | |
| SCHEMBL25916341 | 0.88 | MAPT (0.55) | MAPTTP53RXFP1MEN1KMT2A | |
| SCHEMBL30362797 | 0.87 | MAPT (0.64) | MAPTTP53RXFP1MEN1KMT2A | |
| SCHEMBL25916335 | 0.87 | MAPT (0.64) | MAPTTP53RXFP1MEN1KMT2A | |
| SCHEMBL25916758 | 0.84 | MAPT (0.56) | MAPTTP53RXFP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230235190-A1 | FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS | Crime Science Technology (FR) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230235190-A1 | FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS | TUBB3, TUBA3C, PHB1 | MAPT 318/4885TP53 905/4885RXFP1 1340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.